Norris Perne & French LLP Becton Dickinson & CO Transaction History

Norris Perne & French LLP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 30, 2021	SELL	$232.09 - $256.88 $257,155 - $284,623	-1,108 Closed	0 $0
Q4 2020 Jan 27, 2021	SELL	$221.92 - $245.94 $1,997 - $2,213	-9 Reduced 0.81%	1,108 $277,000
Q3 2020 Oct 26, 2020	SELL	$215.77 - $276.76 $2,805 - $3,597	-13 Reduced 1.15%	1,117 $260,000
Q2 2020 Jul 23, 2020	SELL	$219.9 - $263.41 $45,959 - $55,052	-209 Reduced 15.61%	1,130 $270,000
Q1 2020 Apr 16, 2020	SELL	$195.69 - $279.01 $7.99 Million - $11.4 Million	-40,835 Reduced 96.83%	1,339 $308,000
Q4 2019 Jan 22, 2020	BUY	$236.45 - $266.82 $47,053 - $53,097	199 Added 0.47%	42,174 $11.5 Million
Q3 2019 Oct 24, 2019	SELL	$230.58 - $256.08 $4.96 Million - $5.5 Million	-21,494 Reduced 33.87%	41,975 $10.6 Million
Q2 2019 Jul 19, 2019	BUY	$217.4 - $246.08 $78,698 - $89,080	362 Added 0.57%	63,469 $16 Million
Q1 2019 Apr 29, 2019	SELL	$206.05 - $248.17 $209,758 - $252,637	-1,018 Reduced 1.59%	63,107 $15.8 Million
Q4 2018 Jan 28, 2019	BUY	$204.73 - $257.93 $1.44 Million - $1.82 Million	7,049 Added 12.35%	64,125 $14.4 Million
Q3 2018 Oct 29, 2018	SELL	$233.07 - $256.0 $115,136 - $126,464	-494 Reduced 0.86%	57,076 $14.9 Million
Q2 2018 Jul 24, 2018	BUY	$208.1 - $233.85 $267,408 - $300,497	1,285 Added 2.28%	57,570 $13.8 Million
Q1 2018 Apr 17, 2018	BUY	$205.46 - $240.27 $73,143 - $85,536	356 Added 0.64%	56,285 $12.2 Million
Q4 2017 Jan 23, 2018	SELL	$189.0 - $222.64 $260,631 - $307,020	-1,379 Reduced 2.41%	55,929 $12 Million
Q3 2017 Nov 01, 2017	BUY	$186.89 - $198.9 $10.7 Million - $11.4 Million	57,308	57,308 $11.2 Million

1,738

250M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $63.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Norris Perne & French LLP, based on Form 13F filings with the SEC.

Stay updated on Norris Perne & French LLP with notifications on news.